Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and Performance

23 Aug 2017

Abstract excerpt

OBJECTIVE: To study patient choice regarding testing for sex chromosome aneuploidy (SCA) and the performance of cell-free DNA (cfDNA) screening for SCA. METHODS: Patient choice regarding screening for SCA and factors influencing this choice were evaluated in a single center. In a subsequent two-center study, cases that screened positive for SCA were analyzed to determine the positive predictive value (PPV) for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Share to Genomic variations and chromosomal abnormalities

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prenatal Screening and Diagnostics

Source

Identifiers

PMID: 28848190
DOI: 10.1159/000479507

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and PerformancePMID 28848190Read ↗

Cell‐free DNA screening and sex chromosome aneuploidiesSemantic proximity Read ↗

Performance of prenatal cfDNA screening for sex chromosomesSemantic proximity Read ↗

Clinical accuracy of abnormal cell‐free fetal DNA results for the sex chromosomesSemantic proximity Read ↗

Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA)Semantic proximity Read ↗

Clinical experience with sex chromosome aneuploidies detected by noninvasive prenatal testing (NIPT): Accuracy and patient decision‐makingSemantic proximity Read ↗

Assessment of Fetal Sex Chromosome Aneuploidy Using Directed Cell-Free DNA AnalysisSemantic proximity Read ↗

Implications of fetoplacental mosaicism on cell‐free DNA testing for sex chromosome aneuploidiesSemantic proximity Read ↗

Variation in the decision to terminate pregnancy in the setting of fetal aneuploidySemantic proximity Read ↗

Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidySemantic proximity Read ↗

Confirmation rate of cell free DNA screening for sex chromosomal abnormalities according to the method of confirmatory testingSemantic proximity Read ↗

Prenatal Genetic Diagnosis of a Sex Chromosome Aneuploidy: Parent ExperiencesSemantic proximity Read ↗

Non-Invasive Prenatal Testing for Sex Chromosome Aneuploidy in Routine Clinical PracticeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.